CAS number：319460-94-1 molecular formula：C26H22FN7O
Information AG-13958 AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD). Targets VEGFR
| Chinese alias | N-[2-氟-5-[[3-[(1E)-2-(2-吡啶基)乙烯基]-1H-吲唑-6-基]氨基]苯基]-1,3-二甲基-1H-吡唑-5-甲酰胺 | ||
| English alias | BK72RP7F7D | N-[2-Fluoro-5-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]amino]phenyl]-2,5-dimethylpyrazole-3-carboxamide | BCPP000423 | HY-15492 | A875759 | AG13958 | AG-13958 | AKOS015904194 | BCP9000248 | J-502056 | (E)-N-(2-fluoro-5-(3-(2-(pyridin-2 | ||
| CAS number | 319460-94-1 | molecular formula | C26H22FN7O |
| molecular weight | 467.51 g/mol | Exact mass | ≥99% |
| PSA | 101.000 Ų | logp | 4.3 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
